Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 68382-522

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 68382-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dafad74d 98d3 4119 A9b0 4b45515698be 01)

Chemical structure of Propafenone Hydrochloride, a human prescription drug active ingredient used in extended-release capsules. The structure shows molecular components including aromatic rings, ether and amine groups, and the hydrochloride salt form.*

FDA Label Image

Image (Dafad74d 98d3 4119 A9b0 4b45515698be 02)

Kaplan-Meier survival curve chart showing the proportion of patients without events over time (up to 300 days) for Propafenone Hydrochloride extended-release capsules at 225 mg, 325 mg, and 425 mg twice daily doses compared to placebo. The x-axis represents days, and the y-axis shows the proportion of event-free patients. Patient counts at risk are indicated below the timeline. The chart highlights statistical significance levels (p-values) for comparisons among groups, with a note on patient closeout starting at week 39 (day 273).*

FDA Label Image

Label (Dafad74d 98d3 4119 A9b0 4b45515698be 03)

Label for Propafenone Hydrochloride extended-release capsules, USP 225 mg, in a package containing 60 capsules. The oral dosage form is manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions, child-resistant packaging notice, and a barcode with NDC 68382-522-14.*

FDA Label Image

Label (Dafad74d 98d3 4119 A9b0 4b45515698be 04)

Label for Propafenone Hydrochloride Extended-release Capsules, USP 325 mg, oral dosage form. The package contains 60 capsules, marked Rx only. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions and safety warnings, with a barcode and NDC 68382-523-14 visible.*

FDA Label Image

Label (Dafad74d 98d3 4119 A9b0 4b45515698be 05)

Label for Propafenone Hydrochloride Extended-release Capsules, USP 425 mg, in a package containing 60 capsules. The label includes the NDC 68382-524-14 and indicates the product is for prescription use only. Manufactured by Cadila Healthcare Ltd., India and distributed by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.